Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

24results about How to "Lower immune response" patented technology

Acellular matrix material as well as preparation method and application thereof

The invention provides an acellular matrix material as well as a preparation method and application thereof, and belongs to the technical field of new materials. The preparation method comprises the following steps: pretreating pigskin, carrying out decellularization treatment in an ionic liquid into which carbon dioxide is introduced, carrying out enzymolysis to remove surface antigens, and reacting with ferulic acid and hyaluronic acid / antibacterial peptide compounds to prepare the decellularized matrix material. The prepared acellular matrix material overcomes the problems that a traditional acellular matrix material is high in degradation rate, uncontrollable, poor in mechanical property, prone to causing inflammatory reaction and the like, has excellent biocompatibility, low immunogenicity and biological activity, reduces the degradation rate of a product and improves the mechanical strength of the product.
Owner:深圳市迈捷生命科学有限公司

Composition as well as preparation method and application thereof

The invention discloses a composition as well as a preparation method and application thereof, and relates to the technical field of compound bacterium extract compositions. The compound bacteria comprise schizochytrium limacinum, acremonium terricola and gordonia alcalivorans; the mass ratio of the compound bacterium extract to the antioxidant is 100: (0.5-5). The preparation method of the composition comprises the following steps: adding the antioxidant into the compound bacterium extract, mixing, and drying to obtain the compound bacterium extract. The compound bacterium extract disclosed by the invention is rich in lipid and other components, and when the compound bacterium extract is applied to a laying hen feed, the cholesterol content in eggs can be effectively reduced on the premise of safety, no toxicity, no side effect and no influence on the production performance of laying hens, so that the low-cholesterol eggs are produced.
Owner:HUNAN AGRI UNIV ANIMAL PHARMA

Genetic transformation method and application of muskmelon

The invention provides a genetic transformation method and application of muskmelon. The genetic transformation method comprises the following steps: carrying out co-culture treatment on an infected muskmelon explant and agrobacterium engineering bacteria in a sugar-free culture medium, and the sugar-free culture medium does not contain soluble sugar. By using the method, the co-culture time can be prolonged to 7-9 days, the infection efficiency of agrobacterium tumefaciens can be remarkably improved, the growth of the agrobacterium tumefaciens can be slowed down, agrobacterium tumefaciens pollution in the bud induction process is avoided, meanwhile, the immunoreaction of explants in the co-culture process is reduced, and the genetic transformation efficiency is further improved. Compared with an existing melon genetic transformation method in which co-culture time lasts for 4 days by adopting a sugar-containing culture medium, the genetic transformation method provided by the invention adopts a sugar-free culture medium and the co-culture time is prolonged to 8 days, so that the melon transgenosis efficiency can be improved by 14 times or more. The invention also provides an application of the genetic transformation method in preparation of a melon genetic transformation product.
Owner:HENAN AGRICULTURAL UNIVERSITY

Preparation and application of inhaled liposome and mannose modified chitosan composite nano-carrier

The invention belongs to the field of nano-drug preparations, and particularly relates to a preparation method of a chitosan composite nano-carrier modified by inhaled liposome and mannose and application of the chitosan composite nano-carrier in treatment of acute lung injury. The composite nano-carrier prepared by the invention contains the inhalable liposome, and can directly act on the lung, so that the first-pass effect of the liver is effectively avoided, the side effect of the whole body is reduced, the action time of the medicine is prolonged, and the bioavailability of the medicine is improved. Furthermore, by using mannose-modified chitosan to coat inhaled liposome, the composite nano-carrier can be specifically combined to a mannose receptor on the surface of macrophage, so that slow-release targeted delivery of drugs is realized, and surprisingly, the composite nano-carrier containing the miR-214 inhibitor and curcumin has the advantages that the drug delivery efficiency is greatly improved, and the drug delivery efficiency is improved. The traditional Chinese medicine composition can achieve the effect of synergistically treating acute lung injury at a proper mass ratio.
Owner:GUANGZHOU FIRST PEOPLES HOSPITAL (GUANGZHOU DIGESTIVE DISEASE CENT GUANGZHOU FIRST PEOPLES HOSPITAL GUANGZHOU MEDICAL UNIV THE SECOND AFFILIATED HOSPITAL OF SOUTH CHINA UNIV OF TECH)

Near-infrared light nano probe as well as preparation method and application thereof

The invention discloses a near-infrared light nano probe as well as a preparation method and application thereof. The preparation method of the near-infrared nano probe comprises the following steps: dissolving polylactic acid-co-acetic acid in an acetonitrile solution, and adding lecithin and 1, 2-dipalmitoyl-sn-glycerol-3-phosphatidyl glycol to obtain a solution A; dissolving indocyanine green in an ethanol solution to obtain a solution B; and mixing the solution A and the solution B, and carrying out ultrasonic treatment to obtain the near-infrared nano probe. The near-infrared light nanoprobe can be used for imaging diagnosis of acute kidney injury, and effectively solves the problems of long diagnosis time, poor stability, high in-vivo clearance rate, low cell absorption rate and the like. Compared with existing ICG nano-particles, the ICG nano-particles are high in biological tissue penetrability, high in resolution ratio, low in phototoxicity and good in fluorescence imaging effect in an acute kidney injury model and have wide application prospects in AKI clinical diagnosis.
Owner:SHENZHEN BAOAN DISTRICT PEOPLES HOSPITAL +1

Preparation and application of polyphenol nano-liposome loaded i-PRF skin dressing

The invention is suitable for the technical field of skin dressings, and provides preparation and application of a polyphenol nano-liposome loaded i-PRF skin dressing, the skin dressing comprises oxidized sodium alginate, carboxymethyl chitosan, freeze-dried concentrated growth factors and oleuropein nano-liposomes, the concentration of the oxidized sodium alginate is 0.2-0.5 g / ml, the concentration of the carboxymethyl chitosan is 0.2-0.5 g / ml, the concentration of the freeze-dried concentrated growth factors is 0.2-0.5 g / ml, and the concentration of the oleuropein nano-liposomes is 0.2-0.5 g / ml. The concentration of the carboxymethyl chitosan is 0.2 to 0.5 g / ml, the concentration of the freeze-dried concentrated growth factor is 0.05 to 0.1 g / ml, and the concentration of the oleuropein nano-liposome is 0.125 to 1 ml / g. According to the skin dressing, the biocompatibility of the hydrogel is effectively improved, the sustained drug sustained release characteristic is shown, and the skin dressing has outstanding performance in the aspect of promoting wound healing.
Owner:JILIN UNIVERSITY

Locally anticoagulant acellular bone matrix composite material and preparation method thereof

The invention relates to the technical field of biological materials, in particular to a local anticoagulation acellular bone matrix composite material and a preparation method thereof.The preparation method comprises the following steps that S1, bone tissue is obtained and treated, and an acellular bone matrix is prepared; s2, mixing an anticoagulant with the acellular bone matrix to form an anticoagulant compound; s3, mixing the anticoagulant compound with a biocompatible carrier to form a final composite material; and S4, preparing the composite material into an implant or a stent with a required shape through a molding and curing process. By arranging the acellular bone matrix, the natural structure and biological activity of the bone matrix are reserved to the maximum extent, and meanwhile, all cell components are removed, so that immunogenicity and pathogen transmission are reduced; by adding the anticoagulant, discomfort can be reduced after the local anticoagulant acellular bone matrix composite material is implanted into a human body, and the problems that in the prior art, an acellular bone matrix has the blood coagulation risk, and incompletely-treated bone tissue has immunological rejection are solved.
Owner:FIRST HOSPITAL AFFILIATED TO GENERAL HOSPITAL OF PLA

Stem cell-derived apoptotic extracellular vesicle with iron homeostasis regulation effect and application of stem cell-derived apoptotic extracellular vesicle in preparation of medicine for treating iron-deficiency anemia

PendingCN119220490Areduce overloadPrecise deliveryCell dissociation methodsSkeletal/connective tissue cellsPeriodontal ligament stem cellsIron levels
The invention provides stem cell-derived apoptotic extracellular vesicles (ApoEVs) with an iron homeostasis regulation effect and application of the stem cell-derived apoptotic extracellular vesicles in preparation of a medicine for treating iron-deficiency anemia, and belongs to the technical field of biological medicines. The ApoEVs is an outer vesicle separated from apoptotic cells derived from human periodontal ligament stem cells, and can effectively recover the iron level in low-iron cells induced by DFOM, up-regulate the expression of iron storage protein and regulate the level of iron export protein, thereby improving the iron homeostasis of the cells. Meanwhile, the ApoEVs have good biocompatibility and safety, and a new strategy is provided for treatment of iron-deficiency anemia.
Owner:STOMATOLOGICAL HOSPITAL OF CHONGQING MEDICAL UNIV

ISG15 overexpression cell line, SRM-enriched exosome as well as preparation method and application of ISG15 overexpression cell line and SRM-enriched exosome

The invention discloses an ISG15 overexpression cell line, an SRM-enriched exosome as well as a preparation method and application of the ISG15 overexpression cell line and the SRM-enriched exosome, and ISGylation modification of spermidine synthase SRM is induced by constructing an ISG15 overexpression stably transfected cell line, so that packaging and sorting of the spermidine synthase SRM into the exosome are promoted. The technical scheme disclosed by the invention shows that the spermidine synthase transmitted by the exosome has biological activity and can catalyze to generate spermidine after being absorbed by target tissues / target cells, so that the spermidine synthase has wide application prospects in multiple aspects of disease treatment, medical care, beauty treatment, young keeping and the like. In addition, other protein or polypeptide drugs can be modified through a genetic engineering technology to be subjected to ISGylation modification so as to be wrapped in the exosome, and simultaneous administration of multiple proteins is realized.
Owner:WUHAN UNIV

Genetic transformation method of PEG / CaCl2 mediated Penicillium citrinum

The invention provides a PEG / CaCl2 mediated Penicillium citrinum genetic transformation method, and belongs to the technical field of microbial genetic transformation, and the method comprises the following steps: adding a target gene segment into Penicillium citrinum protoplast suspension, and carrying out an ice bath reaction; the target gene segment is obtained by taking pJET-hph-02944 plasmid as a template and carrying out PCR (Polymerase Chain Reaction) amplification by adopting a hygromycin B resistance gene primer pair with gene sequences as shown in SEQ ID No. 1 and SEQ ID No. 2; adding a PTC (Positive Temperature Coefficient) buffer solution into the mixed system, uniformly mixing and standing; continuously adding a TB3 liquid culture medium containing ampicillin, and carrying out recovery culture; uniformly mixing the resuscitated protoplast with a molten TB3 solid culture medium, pouring a plate, and carrying out dark culture for the first time; then covering a TB3 solid culture medium containing hygromycin B and ampicillin, carrying out secondary dark culture to obtain a transformant, and transferring the transformant to a PDA plate containing hygromycin B for screening. According to the method, CaCl2-PEG is adopted for mediated transformation of Penicillium citrinum, the transformation efficiency is higher, and the transformation speed is higher.
Owner:KUNMING UNIV OF SCI & TECH

Hexagonal boron nitride nano-particles camouflaged by hybrid cell membrane as well as preparation method and application of hexagonal boron nitride nano-particles

The invention discloses a hybrid cell membrane disguised hexagonal boron nitride nano-particle as well as a preparation method and application thereof, relates to the technical field of medicines, and aims to solve the problems of poor targeting property and biocompatibility of a boron carrying agent, insufficient in-vivo stability and tumor accumulation capacity of nano-particles and the like in BNCT tumor treatment in the prior art. The composite material comprises hexagonal boron nitride nanoparticles and a hybrid cell membrane coating the peripheries of the hexagonal boron nitride nanoparticles, and the hybrid cell membrane is formed by fusing a macrophage cell membrane and a tumor cell membrane. The targeting property and biocompatibility of the boron carrying agent and the in-vivo stability and tumor accumulation capacity of nanoparticles can be effectively enhanced, and the BNCT treatment effect of glioma is improved.
Owner:GENERAL HOSPITAL OF NUCLEAR IND

Application of traditional Chinese medicine compound preparation in preparation of medicine for repairing myocardial injury caused by sepsis

The invention belongs to the technical field of traditional Chinese medicines, and discloses application of a traditional Chinese medicine compound preparation in preparation of a medicine for repairing myocardial injury caused by sepsis. The traditional Chinese medicine compound preparation is prepared from the following raw materials in parts by weight: 3-20 parts of red ginseng, 3-25 parts of radix aconiti carmichaeli, 5-30 parts of semen coicis and 2-20 parts of exocarpium citri grandis. The traditional Chinese medicine compound preparation acts on sepsis cardiomyopathy in a multi-link and multi-target mode, the treatment mode is converted from improvement of a short-term hemodynamic state to a long-term repair strategy, the re-hospitalization rate and the case fatality rate of patients with sepsis cardiomyopathy are further reduced, the life quality of the patients is improved, and the defects of western medicines are overcome. The medicine for repairing myocardial injury caused by sepsis is a medicine for resisting sepsis cardiomyopathy by inhibiting immune response generated by macrophages, reducing NO release and inhibiting generation of IL-1beta, IL-6 and TNF-alpha cell factors.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE +1

Application of multi-target melanocortin receptor stimulant in preparing medicine for preventing and treating pemphigus

The invention provides application of a multi-target melanocortin receptor stimulant in preparation of a medicine for preventing and treating pemphigus, and belongs to the technical field of medicines. The invention provides application of a compound WP302 in preparation of drugs for prevention, treatment or adjuvant treatment of pemphigus. The compound WP302 is a good MC1R, MC3R and MC4R multi-target agonist, plays a role through multiple pathophysiological mechanisms, not only has a remarkable curative effect in the aspects of oxidation resistance and inflammation resistance, but also can regulate immune response and promote tissue healing, and a brand new treatment strategy is provided. The medicine is expected to overcome the limitation of the existing treatment method, provides a safer and more effective treatment choice for pemphigus patients, and remarkably reduces long-term side effects.
Owner:ZHEJIANG WANBANG PHARMA

Treated cell material used in biological tissue repair

It is desirable to provide a novel biomaterial and the like for tendon repair. Provided is a biomaterial for tendon repair containing a hydrogel formed by means of a cross-linking reaction between a reactive group A and a reactive group B, wherein the hydrogel contains a water-soluble polymer having the reactive group A, and mesenchymal stem cells having the reactive group B.
Owner:MOCHIDA PHARM CO LTD +2

Low-immunogenicity AAV gene therapy vector based on polynucleotide as well as preparation method and application of low-immunogenicity AAV gene therapy vector

The invention relates to the field of gene therapy, in particular to a low-immunogenicity AAV gene therapy vector based on polynucleotide and a preparation method and application thereof, and the vector comprises transgene for coding therapeutic protein, modified polynucleotide, low-immunogenicity AAV capsid protein and an immunoregulation module; the transgene is disposed between inverted terminal repetitions of the AAV; the low-immunogenicity AAV capsid protein is selected from a wild type of AAV5, AAV8 or AAV9 or a modified variant of the wild type of AAV5, AAV8 or AAV9; the immunoregulation module comprises a miRNA (micro Ribonucleic Acid) or shRNA ( Through polynucleotide modification and an immunoregulation module, the immunoreaction is reduced, and the stability and continuous expression ability of the AAV gene therapy vector in a host are improved; by selecting the AAV capsid protein, the transduction efficiency of the vector in a specific tissue is improved, so that the vector can reach a target tissue more effectively.
Owner:瑞吉明(山东)生物科技有限公司

Engineering strain for synthesizing gamma-poly-L-glutamic acid and application thereof

The invention discloses a gamma-PGA synthetase gene cluster pgsBCA '. The gamma-PGA synthetase gene cluster pgsBCA' is formed by sequentially connecting genes pgsB, pgsC and pgsA 'in series, the genes pgsB and pgsC are derived from a gamma-PGA synthetase gene cluster BA-pgsBCA of the bacillus altitudinis; the gene pgsA'is derived from a gamma-PGA synthetase gene cluster BM-pgsB 'C' A 'of bacillus megatherium. Bacillus amyloliquefaciens CF of which a genome knockout polyglutamate synthetase gene cluster is used as a host, and a recombinant polyglutamate synthetase gene cluster pgsBCA'is subjected to free expression through plasmids, so that a gene engineering strain capable of synthesizing gamma-L-PGA is obtained. When the strain is used for producing gamma-L-PGA in a 5L fermentation tank through amplification fermentation, the maximum yield can reach 10.5 g / L. Besides, the gamma-poly-L-glutamic acid is free of cytotoxicity and low in immunogenicity, so that the gamma-poly-L-glutamic acid has a wide application prospect in the fields of preparation of wound dressings, in-vivo absorption materials and the like. The invention provides a new material basis and technical support for application and development of polyglutamic acid in the fields of medicine and related biomedicine.
Owner:NANJING TECH UNIV

Acellular dermal matrix and cross-linking modification method thereof

The invention belongs to the field of medical materials, and particularly relates to an acellular dermal matrix and a cross-linking modification method thereof. According to the method, the acellular dermal matrix (ADM) is subjected to cross-linking modification by adopting glutamine transaminase (TG enzyme) in a mild and easy-to-operate manner, so that the physical and mechanical properties, the biocompatibility and the biological activity of the acellular dermal matrix (ADM) are improved. The thermal denaturation temperature, the thermal shrinkage temperature, the tensile strength and the like of the ADM dressing modified by glutamine transaminase (TG enzyme) are remarkably improved, and the ADM dressing has low immunogenicity and controllable degradability. The method can be used for preparing high-end dressings, hemostatic membrane materials, biological tissue patches, soft tissue repair materials, tissue engineering scaffold materials and the like, and has wide clinical application prospects.
Owner:成都科乐金生物科技有限责任公司

Universal circulating perfusate rich in concentrated red blood cells and preparation method of universal circulating perfusate

The invention provides a universal circulating perfusate rich in concentrated red blood cells and a preparation method of the universal circulating perfusate. The method comprises the following steps: separating and concentrating red blood cells from O-type whole blood, and removing plasma, white blood cells and blood platelets; adding nutrient substances into the concentrated red blood cells; trehalose is added into the mixed solution of the nutrient substances and the concentrated red blood cells, ultrasonic vibration is carried out, and the red blood cells are promoted to absorb the trehalose. According to the perfusate disclosed by the invention, the preservation time limit of the in-vitro fractured limb is broken through 6-8 hours, the ischemia reperfusion injury degree of the in-vitro fractured limb is reduced to the maximum extent, the replantation time limit of the in-vitro fractured limb is prolonged, and the in-vitro fractured limb can obtain a better function after replantation.
Owner:ZHONGNAN HOSPITAL OF WUHAN UNIV

Preparation method of animal-derived decellularized tissue scaffold material with high biocompatibility

InactiveCN119633179AReduce residual ratelower immune responseProsthesisGenipinDisinfectant
The invention discloses a preparation method of a high-biocompatibility animal-derived decellularized tissue scaffold material, and relates to the technical field of cell tissue preparation. The method comprises the following steps: washing tissues such as small intestines of pigs with normal saline containing double antibodies and lysozyme; oscillating by using a mixed solution of TritonX-100 and the like, treating by using a solution of nuclease and the like, digesting by using a mixed solution of multiple enzymes, and washing by using ultrapure water containing chitosan; then carrying out ultrasonic disinfection by using a disinfectant containing nano-silver, and sealing by using a solution containing fetal calf serum and the like; after freeze drying, genipin is used for cross-linking and loading growth factors and the like, and finally a dopamine solution is used for modification, so that the scaffold has better hydrophilicity and cell adhesiveness. The cell residue rate of the scaffold is lower than 3%, the nucleic acid residue is low, and the immunogenicity is effectively reduced; the composite material has the advantages that extracellular matrixes are reserved, the mechanical property is good, the controllable bioactive substance release function is achieved, the characteristics of antibiosis, antioxidation and the like are achieved, the biocompatibility is good, and the application prospect is wide.
Owner:深圳市迈捷生命科学有限公司

Screen for capturing tumor cells in human blood

The invention provides a capturing screen for tumor cells in human blood, and relates to the technical field of biomedical engineering.The capturing screen comprises a screen body, according to cells of different sizes, large-size cells are captured through a physical method, small-size cells are removed, and the captured cells are dyed through an immunostaining method; the screen body is made of nickel alloy, the nickel alloy has good mechanical performance and corrosion resistance, so that the screen body has long service life and stability in biological liquid such as blood, and the nickel alloy is commonly used for manufacturing implants and the like in the field of biomedicine and has good biocompatibility. Compared with the prior art, interference to blood components and immunoreaction of a patient are reduced, cleaning and disinfection are easy, repeated use of the screen body is facilitated, the risk of cross infection is reduced, the outer ring diameter of the screen body is 8.8 mm, the inner ring diameter of the screen body is 6.0 mm, and due to the design, directional capturing is facilitated, namely only cells in a specific area are captured.
Owner:SUZHOU BOFU BIOMEDICAL TECH CO LTD

Preparation and application of an inhalable liposome and mannose-modified chitosan composite nanocarrier

The present invention belongs to the field of nano drug preparations, and specifically relates to a method for preparing a composite nanocarrier using inhalable liposomes and mannose-modified chitosan, and its application in the treatment of acute lung injury. The composite nanocarrier prepared by the present invention contains inhalable liposomes, which can act directly on the lungs, effectively avoid the first-pass effect of the liver, reduce systemic side effects, prolong the action time of the drug, and improve the bioavailability of the drug. Furthermore, by using mannose-modified chitosan to coat the inhalable liposomes, the composite nanocarrier can be specifically bound to the mannose receptor on the surface of macrophages, thereby achieving sustained-release targeted delivery of the drug, and surprisingly, the composite nanocarrier containing two drugs, miR-214 inhibitor and curcumin, can achieve the effect of synergistic treatment of acute lung injury under a suitable mass ratio.
Owner:GUANGZHOU FIRST PEOPLES HOSPITAL (GUANGZHOU DIGESTIVE DISEASE CENT GUANGZHOU FIRST PEOPLES HOSPITAL GUANGZHOU MEDICAL UNIV THE SECOND AFFILIATED HOSPITAL OF SOUTH CHINA UNIV OF TECH)

Modular tandem repeats of highly platelet-adhesive recombinant type III collagen and its applications

This invention belongs to the field of genetic engineering technology, specifically relating to a modular tandem repeat recombinant type III collagen with high platelet adhesion and its applications. The amino acid sequence of the recombinant type III collagen includes repeating units, with ≥3 repeating units; functional modules are inserted within each repeating unit. This invention integrates multiple discrete platelet-binding sites in type III collagen, designs a tandem repeat structure of different modular sequences (≥3 repeating units), optimizes spatial synergy, optimizes the gene sequence using codon bias, efficiently expresses the gene through a Pichia pastoris expression system, and obtains a high-purity product after purification. The recombinant type III collagen prepared by this invention exhibits good biocompatibility and can significantly promote erythrocyte and platelet adhesion; it can be widely used in wound repair, hemostatic materials, and tissue engineering.
Owner:NORTHWEST UNIV

Application of anti-angiogenesis medicine in improvement of retention rate of soft tissue graft

The invention discloses an application of an anti-angiogenesis drug in improving the retention rate of a soft tissue graft, which inhibits early vascularization of the soft tissue graft by adopting different types of anti-angiogenesis drugs and weakens the immune response of a body to the soft tissue graft, thereby reducing inflammation and immune cells and improving the retention rate of the soft tissue graft. And the retention rate of the soft tissue graft is improved.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Multifunctional composite neural electrode system and preparation method

The invention provides a multifunctional composite neural electrode system and a preparation method, and belongs to the technical field of implanted electrodes, specifically, the multifunctional composite neural electrode system comprises an electrode main body, a circuit adapter plate, a fixed frame, a catheter structure and a replaceable inner core, the electrode main body comprises an insulating substrate, a metal wiring layer and an insulating layer which are stacked in sequence, the electrode main body is provided with an electrical detection site and a leading-out bonding pad, a metal wiring layer at the electrical detection site and the leading-out bonding pad is exposed, the replaceable inner core comprises an implantation guide needle, an optical fiber and an injection inner tube, and the replaceable inner core is inserted from one end, far away from the tip of the electrode main body, of the sleeve, enters the implantation tube through the insertion core and extends out of the far end of the implantation tube. By designing a universal catheter structure and a replaceable inner core, the neural electrode realizes multi-mode nerve detection or stimulation, multiple functions are selected according to actual requirements, and integration of all functional parts is avoided, so that the overall structural size is reduced, and the damage to the brain in a long-term experiment can be reduced.
Owner:PEKING UNIV